Dr reddy adr price
WebBarclays Adjusts Price Target on Dr. Reddy's Laboratories to $66 From $69, Reiterates O.. MT. 2024: Barclays Adjusts Dr. Reddy's Laboratories' Price Target to $69 from $68, Maintains Over.. MT. More recommendations: Financials . Sales 2024: 241 B 2 943 M 2 943 M: Net income 2024: 42 874 M 523 M 523 M: Net cash 2024: 35 489 M 433 M 433 M: WebDr. Reddy's Laboratories Ltd. ADR historical stock charts and prices, analyst ratings, financials, and today’s real-time RDY stock price. Dow Jones, a News Corp company …
Dr reddy adr price
Did you know?
WebDr. Reddy's Laboratories Ltd Stock - RDY Share Price Today, News and Discussion RDY Dr. Reddy's Laboratories Ltd. 511 $53.56 $0.19 (0.35%) Today $0.00 0.00 (0.00%) Pre-Market Market Cap $8.95B Volume (M) 326,607.00 52-Wk High $58.28 52-Wk Low $49.59 About Feed Fundamentals News There is no chart data available for this period 1d 1w … Web1 day ago · Dr. Reddy's Laboratories Ltd. ADR company and executive profile by Barron's. View the latest RDY company infomation and executive bios. ... with the exception of the current price and price ...
WebMar 20, 2024 · Dr Reddy's Labs ADR now meets that criteria, with an increase from 71 to 81 Monday. As you try to find the best stocks to buy and watch , be sure to pay attention to relative price strength.
WebDr. Reddy’s Laboratories Ltd ADR share price live 60.25, this page displays NYSE RDY stock exchange data. View the RDY premarket stock price ahead of the market session … WebDr.Reddy's Laboratories (RDY) stock was down more than 10% on Monday as the company was hit with a court order that stops it from releasing generic Suboxone in the U.S.
WebMar 24, 2024 · Currently, Dr Reddy's Laboratories Ltd (ADR)’s price-earnings ratio is 20.6. Dr Reddy's Laboratories Ltd (ADR)’s trailing 12-month revenue is $2.9 billion with a 15.3% net profit margin. Year-over-year quarterly sales growth most recently was 27.3%. Analysts expect adjusted earnings to reach $3.390 per share for the current fiscal year.
WebDr. Reddy's Laboratories Ltd. ADR balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. ... with the exception of the current price and price history, was supplied ... gastroenterology associates crestview flWebApr 14, 2024 · According to MarketBeat.com, Dr. Reddy's Laboratories has a consensus rating of "Hold" and a consensus target price of $67.00. Dr. Reddy's Laboratories Stock Performance. Shares of RDY opened at $60.28 on Friday. The firm has a market cap of $10.04 billion, a price-to-earnings ratio of 22.33, a PEG ratio of 0.47 and a beta of 0.49. david taylor used cars saint louisWebApr 13, 2024 · Dr. Reddy`s Laboratories Ltd. - ADR (RDY) shares closed today at 0.3% below its 52 week high of $60.45, giving the company a market cap of $10B. The stock is … gastroenterology associates baton rouge laWebApr 11, 2024 · Dr. Reddy’s Laboratories Stock Performance. Shares of RDY opened at $58.97 on Tuesday. The company has a quick ratio of 1.72, a current ratio of 2.30 and a debt-to-equity ratio of 0.01. gastroenterology associates bristol vaWebUnder the terms of the agreement, Dr. Reddy's will acquire the portfolio for an upfront payment of approximately $90 million in cash, with contingent payments of up to $15 … david taylor used carsWebGet the latest Dr Reddy's Laboratories Ltd (DRREDDY) real-time quote, historical performance, charts, and other financial information to help you make more informed … gastroenterology associates evansville inWeb12 rows · Complete Dr. Reddy's Laboratories Ltd. ADR stock information by Barron's. View real-time RDY stock ... david taylor urologist morristown nj